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The proinflammatory cytokine, tumor necrosis
factor (TNF), has been implicated in the pathophysio-
logic features of the systemic inflammatory response
syndrome and multiple organ failure.1,2 TNF acts by
binding to target cells at specific TNF receptors (TNF-
Rs) of 55 kDa and 75 kDa molecular mass (p55 and
p75), respectively.3,4 The binding of TNF leads to
cleavage of these receptors from target cells and their
release into the circulation as soluble TNF receptors
(sTNF-Rs),5 and it has been suggested that the levels
of sTNF-Rs may reflect the degree of TNF-induced
tissue injury.6,7 The finding that high concentrations
of sTNF-Rs act as endogenous TNF antagonists and
that low concentrations may slow down TNF clear-
ance, so prolonging its activity,7 has led to the sugges-
tion that the administration of exogenous sTNF-Rs
may ameliorate the effects of TNF.
Circulating TNF has been demonstrated in elec-
tive and emergency aortic surgery,8-16 and elevated
levels of sTNF-Rs have been detected in patients
who undergo repair of nonruptured abdominal aor-
tic aneurysm (AAA) 16,17 and after the operation in
patients with ruptured AAA.16 To date, however, no
study has examined the levels of sTNF-Rs during the
periods of hemorrhagic shock, lower torso ischemia,
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and early reperfusion, which occur in ruptured AAA
repair. This is clinically relevant because, although
experimental data suggest that the administration of
exogenous sTNF-R before aortic crossclamping is
associated with a reduction in circulating TNF and
subsequent lung injury in an animal model,18
human studies have shown that elevated levels of
endogenous sTNF-Rs are actually associated with
the development of multiple organ failure and
increased mortality rates in sepsis,19 pancreatitis,20
and multiple trauma.21 Although exogenous sTNF-
R therapy may ameliorate the adverse effects of TNF
in elective aortic surgery in which endogenous levels
are low, it may be ineffective if endogenous levels are
high in patients who undergo ruptured AAA
repair.19 The aims of this study were to examine ser-
ial changes in sTNF-Rs occurring during emergency
repair of ruptured infrarenal AAA and to compare
the findings with patients who undergo elective
repair of nonruptured AAA.
METHODS
Patients. Sixteen patients (14 men and 2
women; median age, 75 years; range, 65-86 years)
who underwent operation for ruptured infrarenal
AAA and 10 patients (eight men and two women;
median age, 69 years; range, 58-80 years) who
underwent operation for asymptomatic nonruptured
infrarenal AAA were prospectively studied. Lothian
Region Ethical Committee approval and fully
informed written consent from all patients were
obtained. In patients who underwent operation for
ruptured AAA, the median delay between the onset
of symptoms of rupture and hospital admission was
5 hours (range, 3-14 hours). All patients had at least
one documented episode of hypotension (systolic
blood pressure less than 100 mm Hg) before the
surgical procedure. In patients who underwent an
operation for asymptomatic nonruptured AAA, the
median anteroposterior diameter of the aneurysm
measured by abdominal ultrasonography was 6.5 cm
(range, 5.5-8.0 cm).
Operative methods. Ruptured AAA was defined
as the presence of fresh retroperitoneal blood at the
time of the operation. Three patients had retroperi-
toneal and intraperitoneal rupture. Patients with rup-
ture were given general anaesthesia, and patients with
nonruptured AAA were given combined general and
epidural anesthesia. All patients underwent AAA
repair through a transverse supraumbilical incision
with infrarenal aortic clamping. A Dacron tube graft
was inserted in 17 patients (12 patients with rupture,
5 patients with nonrupture), aortobi-iliac graft in five
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 3 Adam et al 515
(one patient with rupture, four patients with nonrup-
ture) and aortobifemoral graft in four patients (three
patients with rupture, one patient with nonrupture).
Aortic clamp time was defined as the time between
aortic clamp placement and the completion of the dis-
tal anastomosis for patients who underwent tube graft
repair and the completion of the first and second dis-
tal anastomoses for patients who underwent repair
with a bifurcated graft.
Sample collection. The pathophysiology of
ruptured AAA repair can be divided into three phas-
es. First, there is a period of whole-body hypoperfu-
sion as the result of hypovolemic shock. Second,
there is a period of profound lower body ischemia
after aortic clamp placement. Finally, if repair is suc-
cessful, there is a period of reperfusion. The sam-
pling points were chosen to reflect the maximum
effect of each of the three pathophysiologic phases
of ruptured AAA repair. Blood was sampled from an
indwelling arterial line immediately before the
induction of anesthesia (sample A); immediately
before release of the aortic clamp (sample B); and 5
minutes (sample C), 6 hours (sample D), and 24
hours (sample E) after aortic clamp release. For
patients who underwent repair with a bifurcated
graft, sampling points C, D, and E were relative to
reperfusion of the first limb. Blood (9 mL) was col-
lected into a clot activator for the estimation of
serum levels sTNF-Rs p55 and p75. Samples were
placed immediately on ice and centrifuged within 30
minutes of collection at 3000 revolutions per minute
for 30 minutes at 4°C (equivalent to 1400g). Serum
was separated and stored at −70°C for later batch
analysis.
Assays of soluble TNF receptors p55 and
p75. Serum levels of sTNF-Rs p55 and p75 were
detected by enzyme-linked immunosorbent assay,
with monoclonal and polyclonal anti-sTNF-R p55
and p75 antibodies (donated by Dr W. A. Buurman,
Maastricht, The Netherlands).22 Purified sTNF-R
p55 and p75 were used to construct standard
curves. The lower limit of detection of the sTNF-R
p55 assay was 0.2 ng/mL and of the sTNF-R p75
assay was 2 ng/mL.
Statistical methods. The Mann-Whitney U
test was used to test whether the medians of two
samples were significantly different from each other
and to examine whether there was a difference in
assay levels between patients with ruptured AAA
who had (1) one or more cardiovascular complica-
tions, (2) one or more respiratory complications,
(3) sepsis syndrome, or (4) renal failure compared
with patients who did not have these complications.
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The Kruskall-Wallis one-way analysis of variance was
used to examine whether assay levels changed sig-
nificantly over the five sampling points in the rup-
tured and nonruptured AAA groups separately. In
addition, the differences between the average rank-
ings were examined to determine whether they
exceeded a precalculated critical value.23 In patients
who underwent operations for ruptured AAA,
Spearman’s rank correlation was calculated between
the assay levels and the following clinicopathologic
variables: duration of symptoms before hospital
admission, volume of preoperative fluid resuscita-
tion, preoperative serum creatinine level, operative
blood loss, volume of intraoperative fluid resuscita-
tion (crystalloid and colloid and packed red blood
cells), and aortic crossclamp time. Multiple regres-
sion was used to examine the independent effect of
these variables and the assay levels at each of the five
sampling points. Age and sex had forced entry, and
a forward-stepping procedure was used. A probabil-
ity value of less than .05 was regarded as statistical-
ly significant. When levels of sTNF-Rs were below
the limit of detection of the assay, the minimum
detection concentration was assigned to that sam-
ple, and statistical analysis was performed with this
convention.20
RESULTS
Clinical data. Operative data for both groups of
patients are summarized in Table I. All patients with
ruptured AAA were admitted to the Intensive Care
Unit (ICU) for postoperative care and ventilatory
support. The median duration of ICU stay was 3
days (range, 0.5-24.1 days). The median duration of
ventilatory support was 0.9 days (range, 0.4-18.8
days), and seven patients received ventilatory sup-
port for more than 4 days. All patients who under-
went operations for nonruptured AAA were admit-
ted to the intermediate care unit after the operation,
and no patient was admitted to the ICU or required
ventilatory support. Major postoperative complica-
tions developed in 13 patients who underwent oper-
ation for rupture and in 4 patients who underwent
operation for nonruptured AAA (Table II). Three
patients with rupture and six patients with nonrup-
ture had no postoperative complications. All patients
survived to 24 hours after repair. Five patients
(31.2%) with ruptured AAA died in the hospital.
There were no deaths after the repair of nonrup-
tured AAA.
Assays of soluble TNF receptors p55 and
p75. The median values for sTNF-Rs p55 and p75
are shown in Table III. Both types of sTNF-R were
detectable at one or more sampling points in all
patients with ruptured AAA and in 9 of 10 patients
with nonruptured AAA.
Five minutes and 24 hours after aortic clamp
release, levels of sTNF-R p55 were significantly
higher in patients with ruptured compared with
nonruptured AAA. There was no significant change
in the levels of sTNF-R p55 as a function of time in
either group.
Table I. Operative patient data
Ruptured AAA median (range) Nonruptured AAA median (range)
(n =16) (n =10) P value*
Preoperative
Crystalloid administration (L) 0.5 (0.1-4.0) — —
Colloid administration (L) 0 (0-1.5) — —
Intraoperative
Operation time (min) 110 (70-250) 160 (85-285) NS
Total aortic clamp time (min) 75 (30-180) 75 (30-150) NS
Tube graft (min) 69 (35-180) 77 (45-120) —
Bifurcate graft: first limb (min) 95 (32-130) 68 (38-90) —
Bifurcate graft: second limb (min) 113 (42-140) 71 (52-110) —
Measured blood loss (L) 3.1 (1.0-11.0) 2.4 (0.4-6.0) NS
Crystalloid administration (L) 2.3 (0.5-6.0) 1.9 (1.0-4.0) NS
Colloid administration (L) 1.5 (0-2.3) 1.5 (1.0-4.1) NS
Packed red blood cell administration (units)† 8 (5-22) 4 (0-10) .004
Fresh frozen plasma administration (units)† 2 (0-12) 0 (0-2) .0003
Platelet administration (bags)‡ 1 (0-1) 0 (0-1) .0007
*Mann-Whitney U test.
†300 mL.
‡One bag of platelet transfusion = 4 pooled units (250 mL).
NS, Not significant.
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At all sampling points, levels of sTNF-R p75
were significantly higher in patients with ruptured
compared with nonruptured AAA, and there was a
significant increase in the levels of sTNF-R p75 dur-
ing reperfusion in both groups of patients (Table
III). Six hours after aortic clamp release, levels of
sTNF-R p75 were significantly higher in nonsur-
vivors of ruptured AAA (median, 14.6 ng/mL;
range, 9.7-18.0 ng/mL) compared with survivors
(median, 6.3 ng/mL; range, 2.1-18.5 ng/mL; P =
.036) and patients who underwent operation for
nonruptured AAA (median, 2.5 ng/mL; range, 2.0-
5.9 ng/mL; P = .002). There was no significant dif-
ference in levels of sTNF-R p75 between nonsur-
vivors of rupture, survivors of rupture, and patients
who underwent operation for nonruptured AAA at
any other sampling point.
In patients who underwent operation for rup-
ture, sTNF-R p55 levels immediately before (P =
.015) and 5 minutes after aortic clamp release (P =
.034) were significantly lower in six patients who
subsequently experienced the development of renal
failure compared with 10 patients who did not.
There was not a significant difference in sTNF-R
p75 levels among patients who did and did not have
cardiovascular complications, respiratory complica-
tions, sepsis syndrome, or renal failure.
In patients who underwent operation for rup-
ture, Spearman’s rank test demonstrated a signifi-
cant negative association between aortic crossclamp
time and sTNF-R p55 level immediately before aor-
tic clamp release (r = –0.53), volume of preoperative
fluid resuscitation and sTNF-R p75 level at 24 hours
(r = –0.52), and volume of intraoperative packed red
blood cells and sTNF-R p75 level after 5 minutes of
reperfusion (r = –0.55). After adjustment for age
and sex, multiple regression analysis demonstrated
an independent association between aortic cross-
clamp time and sTNF-R p55 level immediately
before (P = .028) and 5 minutes after aortic clamp
release (P = .028), volume of intraoperative crystal-
loid and colloid resuscitation and sTNF-R p55 level
at 6 hours after aortic clamp release (P = .013), and
volume of preoperative fluid resuscitation and
sTNF-R p75 level at 5 minutes after aortic clamp
release (P = .008).
DISCUSSION
The present study has demonstrated, for the first
time, that hemorrhagic shock, lower torso ischemia,
and early reperfusion occurring in the course of rup-
tured AAA repair are associated with elevated levels
of sTNF-Rs p55 and p75 and that elevated levels of
sTNF-R p75 during the period of early reperfusion
are associated with increased postoperative mortality
rates. Furthermore, sTNF-Rs appeared rapidly after
the onset of hemorrhagic shock and lower torso
ischemia,24 a finding that is more indicative of a
direct relationship between sTNF-R levels and
increased mortality rates than in a previous study
where sTNF-Rs p55 and p75 levels were measured
daily for 5 days after operation.16
Studies that report the time course of TNF and
sTNF-R release in response to lower extremity
ischemia and reperfusion are few and contradictory.
Animal studies have either demonstrated no signifi-
cant increase in TNF levels during ischemia or reper-
fusion,27 a transient increase within minutes of reper-
fusion as the result of washout from the lower
extremities,28 or increased levels during ischemia but
not reperfusion.18 Human studies that have included
a statistical analysis of the time course of TNF release
have failed to demonstrate a significant increase dur-
ing early reperfusion in elective aortic reconstruc-
Table II. Postoperative complications
Ruptured Nonruptured
AAA (n = 16) AAA (n = 10)
Cardiovascular
Atrial fibrillation 5 1
Congestive cardiac failure 5 2
Myocardial infarction 1 0
Stroke 2 0
Lower limb critical ischemia 3 1
Proximal deep venous 2 1
thrombosis
Respiratory
Pneumonia 11 2
Respiratory failure 5 0
Acute respiratory distress 1 0
syndrome
Acute renal failure 6* 1
Disseminated intravascular 2 0
coagulopathy
Sepsis syndrome 3 0
Colon ischemia 1 0
Total parenteral nutrition 5 0
Inotropic support
Adrenaline 5 0
Renal dose dopamine 11 0
Reoperation 3† 1‡
Total 13/16 (81%) 4/10 (40%)
*Three of six patients who experienced the development of acute
renal failure received hemofiltration.
†Patient 1, laparotomy for hemorrhage, femoral thrombectomy,
Hartmann’s procedure for colon ischemia, drainage of infected
pelvic hematoma; patient 2, negative laparotomy for suspected
colon ischemia; patient 3, bilateral below knee amputations for
critical limb ischemia.
‡Popliteal thrombectomy and fasciotomies.
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tion.12-14 To date, two studies have examined sTNF-
R release before and after aortic aneurysm repair.
Froon et al16 measured sTNF-R p55 and p75 levels in
21 patients with ruptured AAA and 9 patients with
nonruptured AAA and demonstrated significantly
higher levels of both sTNF-Rs in shocked patients
and nonsurvivors; Soong et al17 measured sTNF-R
p55 levels in 11 patients with nonruptured AAA and
demonstrated that levels were lower in four nonsur-
vivors but that the postoperative increase was signifi-
cantly greater at 48 hours when compared with sur-
vivors. The present study is the first therefore to
examine sTNF-R release before, during, and early
after ruptured and nonruptured AAA repair.
Although there was no significant change in sTNF-R
p55 levels as a function of time, there was a significant
increase in sTNF-R p75 levels in both groups of
patients at 6 and 24 hours after aortic clamp release.
In contrast to the findings of Froon et al,16 there
was no significant positive association between serum
creatinine and sTNF-R levels in the present study.
Moreover, sTNF-R p55 levels immediately before
and after aortic clamp release were significantly lower
in patients with ruptured AAA who later developed
renal failure compared with those patients who did
not. There was, however, no significant difference in
sTNF-R levels among patients with rupture who did
and did not have cardiovascular, respiratory, or septic
complications.
The association between elevated sTNF-R levels
and increased mortality rates in patients who under-
went operation for ruptured AAA is similar to that
observed by other investigators in acute inflamma-
tory conditions or severe injury.19-21 Elevated lev-
els of sTNF-Rs may indicate that the endogenous
pool of sTNF-Rs is replete19 and this may partly
explain the disappointing results achieved with
exogenous sTNF-R p55 and p75 in patients with
sepsis syndrome and septic shock.25,26 It is not pos-
sible to determine from the present study whether
therapeutic intervention with exogenous sTNF-Rs
would ameliorate the adverse effects of TNF in
lower extremity ischemia and ruptured AAA
repair.10,16,27,28 However, a recent animal study of
infrarenal aortic crossclamping demonstrated a sig-
nificant reduction in circulating TNF levels, nitric
oxide production, and subsequent lung injury when
exogenous sTNF-R p55 was administered before
aortic clamp placement.18 In the present study,
endogenous sTNF-R levels were significantly lower
in patients who underwent repair of nonruptured
AAA compared with those who underwent opera-
tion for ruptured AAA. One can speculate that
exogenous sTNF-R therapy may ameliorate the
adverse effects of TNF in elective aortic surgery
where endogenous levels of sTNF-Rs are low but
may have limited efficacy in patients with hemor-
rhagic shock before ruptured AAA repair,19 in which
the concentrations of sTNF-Rs observed in the pre-
sent study would have been sufficient to effectively
antagonize the effects of circulating TNF in vitro.29
In conclusion, these data demonstrate that hem-
orrhagic shock, lower torso ischemia, and early
reperfusion that occur in the course of ruptured
Table III. Serum levels of soluble sTNF-Rs p55 and p75
Ruptured AAA* Nonruptured AAA†
median (range) median (range)
(n = 16) (n = 10) P value*
sTNF-R p55 level (ng/mL)
Immediately before induction of anesthesia (A) 1.3 (0.2-4.9) 0.8 (0.2-1.4) NS
Immediately before aortic clamp release (B) 1.1 (0.2-2.8) 0.6 (0.2-1.1) NS
5 minutes after aortic clamp release (C) 1.1 (0.2-3.5) 0.5 (0.2-1.2) .018
6 hours after aortic clamp release (D) 1.5 (0.3-5.3) 0.7 (0.2-4.0) NS
24 hours after aortic clamp release (E) 1.6 (0.2-4.4) 0.8 (0.2-2.1) .042
Significant differences between samples† None None
sTNF-R p75 level (ng/mL)
Immediately before induction of anesthesia (A) 4.0 (2.0-14.7) 2.1 (2.0-9.0) .028
Immediately before aortic clamp release (B) 3.3 (2.0-9.1) 2.0 (2.0-2.2) .0005
5 minutes after aortic clamp release (C) 3.2 (2.0-9.7) 2.0 (2.0-2.2) .0013
6 hours after aortic clamp release (D) 10.0 (2.1-18.5) 2.5 (2.0-5.9) .0009
24 hours after aortic clamp release (E) 11.1 (2.4-23.6) 2.6 (2.0-7.3) .0022
Significant differences between samples† B-D, B-E, C-D, C-E B-D, B-E <.05
NS, Not significant.
*Mann-Whitney U test.
†Kruskall-Wallis test.
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AAA repair are associated with elevated levels of the
sTNF-Rs and that elevated levels of sTNF-R p75
during the period of early reperfusion are associated
with increased mortality rates. The fact that the
endogenous pool of sTNF-Rs may be replete and
that elevated endogenous levels are associated with
increased mortality rates suggests that sTNF-R ther-
apy may have limited efficacy in patients who under-
go ruptured AAA repair.
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